Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice.

导出 LinkOut

翻译打印收藏纠错

第一作者： Antoine,Thiery-Vuillemin

第一单位： Department of Medical Oncology, University Hospital, Besançon, France; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur, Ingénierie Cellulaire et Génique, Besançon, France.

作者： Antoine,Thiery-Vuillemin ^[1] ; Tiphaine,Cholley ^[2] ; Fabien,Calcagno ^[1] ; Marion,Hugues ^[2] ; Tristan,Maurina ^[3] ; Samuel,Limat ^[4] ; Thierry,Nguyen Tan Hon ^[3] ; Hamadi,Almotlak ^[3] ; Guillaume,Mouillet ^[3] ; Virginie,Nerich ^[5]

作者单位： Department of Medical Oncology, University Hospital, Besançon, France; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur, Ingénierie Cellulaire et Génique, Besançon, France. ^[1] Department of Pharmacy, University Hospital, Besançon, France. ^[2] Department of Medical Oncology, University Hospital, Besançon, France. ^[3] Department of Pharmacy, University Hospital, Besançon, France; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur, Ingénierie Cellulaire et Génique, Besançon, France. ^[4] Department of Pharmacy, University Hospital, Besançon, France; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur, Ingénierie Cellulaire et Génique, Besançon, France. Electronic address: v1nerich@chu-besancon.fr. ^[5]

关键词 Antiangiogenic therapy Metastatic renal-cell carcinoma Prognostic factors Survival Targeted therapy mTOR inhibitors